SCHEMBL10239559

SCHEMBL10239559

O=S(=O)(Nc1cccc2c1CNCC2)c1ccc(Cl)c2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNMT P11086 5/20 0.47
ALDH1A1 P00352 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
RXFP1 Q9HBX9 1/20 0.44
HTR2C P28335 1/20 0.44
HTR2B P41595 1/20 0.44
WDR5 P61964 1/20 0.43
GAA P10253 2/20 0.41
KDM4E B2RXH2 1/20 0.41
LMNA P02545 1/20 0.41
HTT P42858 1/20 0.41
ADRA2A P08913 1/20 0.41
ADRA2B P18089 1/20 0.41
ADRA2C P18825 1/20 0.41
GHSR Q92847 1/20 0.41
PRCP P42785 1/20 0.39
POLB P06746 2/20 0.38
TAAR1 Q96RJ0 1/20 0.38
HTR6 P50406 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9960120 0.99 PNMT (0.46) PNMTALDH1A1MEN1KMT2ARXFP1
SCHEMBL10238833 0.94 PNMT (0.51) PNMTALDH1A1MEN1KMT2AHTR2C
Hydrochloric Acid SCHEMBL9960241 0.93 PNMT (0.50) PNMTALDH1A1MEN1KMT2AHTR2C
SCHEMBL10238832 0.91 ALDH1A1 (0.44) PNMTALDH1A1MEN1KMT2ARXFP1
Hydrochloric Acid SCHEMBL9960056 0.90 ALDH1A1 (0.44) PNMTALDH1A1MEN1KMT2ARXFP1
SCHEMBL10238650 0.86 PNMT (0.46) PNMTALDH1A1MEN1KMT2AGAA
Hydrochloric Acid SCHEMBL9960372 0.85 PNMT (0.46) PNMTALDH1A1MEN1KMT2AGAA
SCHEMBL10238659 0.85 HTR2C (0.42) PNMTALDH1A1MEN1KMT2AHTR2C
SCHEMBL10238852 0.85 HTR6 (0.51) PNMTALDH1A1GAALMNAGHSR
Hydrochloric Acid SCHEMBL9960228 0.84 CYP3A4 (0.43) PNMTALDH1A1MEN1KMT2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2007729-B1 SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUNDS, THEIR PREPARATION AND USE IN MEDICAMENTS ESTEVE LABOR DR (ES) 2012-06-27 EP disclosed
US-20090209528-A1 SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUND, THEIR PREPARATION AND USE IN MEDICAMENTS LABORATORIOS DEL DR. ESTEVE S.A. (ES) 2009-08-20 US disclosed
US-20090209528-A1 SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUND, THEIR PREPARATION AND USE IN MEDICAMENTS LABORATORIOS DEL DR. ESTEVE S.A. (ES) 2009-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090209528-A1 SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUND, THEIR PREPARATION AND USE IN MEDICAMENTS HTR6, HTR5A, HTR7 PNMT 35/4885ALDH1A1 1731/4885MEN1 839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.